Search
for
Sort by
Research 241–270 of 1000+
- Hair Loss in Autoimmune Cutaneous Bullous Disorders
- Coexistence of bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata: a case report of multifactorial autoimmunity in a surgical context
- 608 A clinical study to test the efficacy of VB1953 in clindamycin non-responder acne patients with antibiotic-resistant P. acnes
- 4. Bullous/Mucous Membrane
- Lymphocytic mediated alopecia: histological classification by pattern analysis
- Cutaneous manifestations of systemic lupus erythematosus
- Skin disorders in Parkinson’s disease: potential biomarkers and risk factors
- Cutaneous Lesions in Systemic Lupus Erythematosus
- Bullous pyoderma gangrenosum occurring on a cesarean section scar
- A 15-Year-Old Girl with Trichorhinophalangeal Syndrome Type 1 with Non-ossifying Fibroma in Femur: A Case Report
- Skin
- Recognition and management of <i>Staphylococcus aureus</i> toxin‐mediated disease
- Autoimmunity and autoimmune co-morbidities in psoriasis
- What's new in the pathogeneses and triggering factors of bullous pemphigoid
- Alopecia as a rare but distinct manifestation of pemphigus vulgaris
- Review paper The use of reflectance confocal microscopy in selected inflammatory skin diseases
- Skin health of community-living older people: a scoping review
- Bullous Lichen Planus treated with Oral Minipulse Therapy: A Rare Case Report
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease
- Can male-pattern baldness be prevented?
- A cross-sectional study of cutaneous changes during pregnancy in a tertiary care hospital in Northern India
- LUPUS ERYTHEMATOSUS AND THE SKIN
- Bullous pilomatrixoma: Without a “Shadow” of doubt – Role of ROSE and cytology
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Gouty Alopecia: An Intriguing Manifestation of Disseminated Tophaceous Gout
- STUDY OF CUTANEOUS MANIFESTATIONS IN THYROID DISORDERS
- Skin diseases associated with Agent Orange and other organochlorine exposures.
- News in brief
- First reboxetine trial results reported
- Update on the dermatologic use of systemic glucocorticosteroids